Introduction:
In 2018, reporter Megan Thielking explored the growing trend of ketamine treatments for severe depression in her STAT News article. While ketamine offers hope for patients with treatment-resistant depression (TRD), the rise of for-profit clinics and unregulated practices has raised concerns about its safety and effectiveness.
Key Points for Patients:
- What Is Ketamine?
- Originally used as an anesthetic, ketamine is now being repurposed to treat severe depression, particularly for individuals who haven’t responded to traditional medications.
- Why It’s Promising:
- Ketamine acts quickly, sometimes within hours, to alleviate symptoms of depression.
- It has been particularly effective for those at high risk of suicide.
- Concerns with Clinics:
- Some clinics market ketamine as a miracle cure without sufficient scientific backing.
- Patients are sometimes misled about the duration of effects or the need for repeat treatments.
- Lack of oversight and inconsistent dosing protocols are common issues.
- Patient Stories:
- The article highlights individuals who found life-changing relief from ketamine but also cautions about those who didn’t benefit or experienced setbacks due to poorly managed care.
The VitalPoint for Patients:
Ketamine could offer new hope if you struggle with severe depression, but it’s important to seek treatment at reputable clinics that follow established medical guidelines. Ask your provider about risks, benefits, and long-term plans before starting ketamine therapy.
Learn More:
- https://www.statnews.com/2018/09/24/ketamine-clinics-severe-depression-treatment/